ÜBER DIESE EPISODE
For decades, a single race coefficient embedded in a laboratory equation quietly shaped the trajectory of kidney disease diagnosis and treatment for millions of patients. In this episode, we sit down with Elizabeth Montgomery, a leading voice from the National Kidney Foundation, to unpack the science, the controversy and the sweeping changes behind the transition from CKD-EPI 2009 to the race-agnostic formula for estimated glomerular filtration rate (egfr). From LIS reprogramming and cystatin C adoption to transplant eligibility and health equity, we go deep on what this shift means for clinical laboratories, the laboratory science professionals who run them and the patients whose lives depend on getting it right. If you work in a laboratory, treat kidney disease, or care about equitable medicine — this one is for you.